Evidence map›Paper›PMID 27886782›Full record

ReviewCardiology clinics2017

Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening.

Dan N Tran, Benson Njuguna, Timothy Mercer, Imran Manji, Lydia Fischer, Marya Lieberman, Sonak D Pastakia

Abstract readReview
In one paragraph

Review in Cardiology clinics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dan N TranDepartment of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, IN 46202, USA.
Benson NjugunaDepartment of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, IN 46202, USA; Department of Pharmacy, Moi Teaching and Referral Hospital, PO Box 3, Eldoret 30100, Kenya.
Timothy MercerDepartment of Medicine, Indiana University School of Medicine, 1120 West Michigan Street, Indianapolis, IN 46202, USA.
Imran ManjiDepartment of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, IN 46202, USA; Department of Pharmacy, Moi Teaching and Referral Hospital, PO Box 3, Eldoret 30100, Kenya.
Lydia FischerDepartment of Medicine, Indiana University School of Medicine, 1120 West Michigan Street, Indianapolis, IN 46202, USA.
Marya LiebermanDepartment of Chemistry and Biochemistry, University of Notre Dame, 250 Nieuwland, Notre Dame, IN 46556, USA.
Sonak D PastakiaDepartment of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, IN 46202, USA. Electronic address: spastaki@gmail.com.

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
NCATS NIH HHS UL1 TR001108
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. Eighty percent of CVD deaths occur in low-income and middle-income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate health care systems that limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings so as to address these deficiencies.

Indexed as

Cardiovascular DiseasesDeveloping CountriesCardiovascular AgentsHealth Services AccessibilityHumansPatient-Centered CarePovertySocioeconomic FactorsCardiovascular AgentsAccountabilityAdherenceAvailabilityCardiovascular disease medicinesFalsified and substandard medicinesHealth-system strengtheningLow-income and middle-income countriesPatient-centered access

Identifiers

PMID27886782
PMCPMC9771684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.